This summer, results from the Adjuvant Lapatinib and/or Trastuzumab Treatment Optimization (ALTTO) trial sparked a controversy that is gathering momentum. The results were presented at the annual ...

SAN ANTONIO -- Patients with stage 2 or stage 3 triple-negative breast cancer (TNBC) who had a pathologic complete response (pCR) after presurgery chemotherapy had increased event-free and overall ...

In a recent phase 2 study, nearly half of patients who had resectable stage 3B/C BRAF V600-mutant melanoma achieved pathologic complete response (pCR) – meaning that no active cancer cells are present ...

The claim: PCR creator Kary Mullis said the tests can detect 'anything in anybody' and can't tell you if you're sick Biochemist and PCR test creator Kary Mullis died in 2019, months before the ...

“Most controversies would soon be ended, if those engaged in them would first accurately define their terms, and then adhere to their definitions.” In the article that accompanies this editorial, von ...

Pharmacokinetic and Pharmacodynamic Properties of Calaspargase Pegol Escherichia coli L-Asparaginase in the Treatment of Patients With Acute Lymphoblastic Leukemia: Results From Children's Oncology ...

SAN ANTONIO -- Adding carboplatin to presurgery chemotherapy improved disease-free survival for patients with triple-negative breast cancer (TNBC), according to results from the randomized phase II ...